SESN3 and acute lymphoblastic leukemia: To clarify this discrepancy, rapamycin was used to treat T-ALL cells and the data showed that both SESN3 overexpression and rapamycin treatment resulted in the decreased ATG4B expression at posttranscriptional level but not ATG5.